2,317 results on '"Ueda, Yutaka"'
Search Results
2. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives
3. A single institution’s experience with minimally invasive surgery for ovarian cancer, and a systematic meta-analysis of the literature
4. Novel Strategy for the Management of Cervical Multicystic Diseases
5. Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative
6. Parental gender influences their intention to HPV vaccinate their children, and the association between HPV and COVID-19 vaccination intentions
7. Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix
8. Diagnosis and Management of Vulvar Cancer
9. Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs
10. Occupation switching of $d$ orbitals probed via hyperfine interactions in vanadium dioxide
11. A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations
12. The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan
13. Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governments
14. Attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination: a 7-year follow-up survey in Japan
15. Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer
16. ASO Visual Abstract: Novel Strategy for the Management of Cervical Multicystic Diseases
17. Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy
18. Development of information dissemination methods that contribute to improving maternal and child healthcare using social networking sites: a community-based cross-sectional study in Japan
19. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer
20. Tailoring a new oxyhydride, CaVO3-xHx, with ordered hydride anions
21. Epidemiology of cervical cancer and HPV infection in Asia and Oceania
22. The association of endometriosis with placenta previa and postpartum hemorrhage: a systematic review and meta-analysis
23. Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix
24. Pressure-induced Superconductivity in the Iron-based Ladder Material BaFe2S3
25. Site-Selective Mott Transition in a Quasi-One-Dimensional Vanadate V6O13
26. Temperature and composition phase diagram in the iron-based ladder compounds Ba1-xCsxFe2Se3
27. Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
28. Laparoscopic Radical Hysterectomy
29. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma
30. Supplementary Figure legend from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
31. Supplementary Table 3 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
32. Supplementary Table 7 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
33. Supplementary Table 8 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
34. Supplementary Table 6 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
35. Data from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
36. Supplementary Figure 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
37. Supplementary Table 9 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
38. Supplementary Table 4 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
39. Supplementary Table 5 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
40. Supplementary Table 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
41. Supplementary Figure 1 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
42. Supplementary Table 2 from SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma
43. Suppressed pediatric asthma hospitalizations during the COVID‐19 pandemic in Japan, from a national survey
44. Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002)
45. EP126/#753 IGF2BP2 is the poor prognostic factor of endometrial cancer and regulates the platinum resistance
46. EP289/#884 Lipid molecules identified by metabolome analysis promote the cell proliferation of epithelial ovarian cancer
47. Correction to: Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix
48. Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis
49. Placenta previa with posterior extrauterine adhesion: clinical features and management practice
50. Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.